18,966 Shares in The Cigna Group (NYSE:CI) Bought by Voleon Capital Management LP

Voleon Capital Management LP acquired a new stake in shares of The Cigna Group (NYSE:CI - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 18,966 shares of the health services provider's stock, valued at approximately $5,237,000.

Other hedge funds also recently made changes to their positions in the company. TCTC Holdings LLC acquired a new position in The Cigna Group in the fourth quarter worth approximately $25,000. Collier Financial acquired a new position in shares of The Cigna Group in the 4th quarter worth $32,000. ORG Wealth Partners LLC acquired a new stake in shares of The Cigna Group during the fourth quarter worth $34,000. Compagnie Lombard Odier SCmA purchased a new stake in shares of The Cigna Group during the fourth quarter valued at $37,000. Finally, Transce3nd LLC purchased a new stake in shares of The Cigna Group during the fourth quarter valued at $38,000. Institutional investors and hedge funds own 86.99% of the company's stock.

Insider Buying and Selling

In other news, Director Elder Granger sold 2,376 shares of the stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $310.35, for a total value of $737,391.60. Following the completion of the sale, the director now directly owns 5,471 shares of the company's stock, valued at approximately $1,697,924.85. This represents a 30.28 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO David Cordani sold 26,527 shares of the business's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the transaction, the chief executive officer now directly owns 127,767 shares in the company, valued at $39,367,568.04. This trade represents a 17.19 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 43,751 shares of company stock valued at $13,603,991. Company insiders own 0.70% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Wells Fargo & Company cut their price objective on The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating on the stock in a report on Tuesday, February 4th. Barclays cut their price target on shares of The Cigna Group from $420.00 to $339.00 and set an "overweight" rating on the stock in a report on Friday, January 31st. Sanford C. Bernstein cut shares of The Cigna Group from an "outperform" rating to a "market perform" rating and set a $323.00 price objective on the stock. in a research report on Thursday, February 6th. Oppenheimer reduced their target price on The Cigna Group from $400.00 to $375.00 and set an "outperform" rating for the company in a report on Friday, January 31st. Finally, UBS Group lowered their price target on The Cigna Group from $410.00 to $390.00 and set a "buy" rating on the stock in a report on Monday, February 3rd. Two investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and three have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of $373.56.

The Cigna Group Stock Down 0.3 %

Shares of CI traded down $1.15 during mid-day trading on Friday, hitting $334.03. 2,471,704 shares of the company's stock were exchanged, compared to its average volume of 1,701,932. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70. The Cigna Group has a twelve month low of $262.03 and a twelve month high of $370.83. The firm has a fifty day moving average of $323.21 and a two-hundred day moving average of $310.23. The stock has a market cap of $91.42 billion, a price-to-earnings ratio of 27.29, a P/E/G ratio of 0.98 and a beta of 0.47.

The Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Friday, May 2nd. The health services provider reported $6.74 EPS for the quarter, topping the consensus estimate of $6.35 by $0.39. The firm had revenue of $65.45 billion for the quarter, compared to the consensus estimate of $60.39 billion. The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. The business's quarterly revenue was up 14.4% on a year-over-year basis. During the same period in the prior year, the business posted $6.47 earnings per share. On average, sell-side analysts forecast that The Cigna Group will post 29.77 earnings per share for the current year.

The Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 18th. Investors of record on Tuesday, June 3rd will be issued a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 1.81%. The ex-dividend date is Tuesday, June 3rd. The Cigna Group's dividend payout ratio is currently 49.35%.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.